Clinical trials
Observational Accidental Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Recruiting | 10 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dartmouth-Hitchcock Medical Center | 9 |
| University of Florida | 4 |
| Chang Gung Memorial Hospital | 3 |
| Hôpital NOVO | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Al-Nahrain University | 1 |
| Ankara City Hospital Bilkent | 1 |
| Arrowhead Regional Medical Center | 1 |
| Artoss Inc. | 1 |
| Azienda Ospedaliero, Universitaria Ospedali Riuniti | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Accidental Injuries | 60 |
| Wounds and Injuries | 22 |
| Multiple Trauma | 5 |
| Emergencies | 4 |
| Hemorrhage | 4 |
| Sepsis | 4 |
| Infections | 3 |
| Wounds, Nonpenetrating | 3 |
| Agnosia | 2 |
| Critical Illness | 2 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.